SOPs for BA-BE Studies V 2.0

To establish a consistent and documented procedure for maintaining accurate Investigational Medicinal Product (IMP) accountability logs throughout the lifecycle of the IMP in Bioavailability/Bioequivalence (BA/BE) studies.
Click to read the full article.

To establish a standard process for the destruction or return of Investigational Medicinal Products (IMPs) used in Bioavailability/Bioequivalence (BA/BE) studies, ensuring regulatory compliance and traceability of unused, damaged, or expired products.
Click to read the full article.

To define the process for managing the washout period between two periods of a crossover design in Bioavailability/Bioequivalence (BA/BE) studies, ensuring subject compliance, safety, and data integrity.
Click to read the full article.

To establish a uniform and compliant procedure for conducting exit examinations of study volunteers at the end of each period or study completion in Bioavailability/Bioequivalence (BA/BE) studies.
Click to read the full article.

To establish a standardized procedure for providing compensation and reimbursement to volunteers who participate in Bioavailability/Bioequivalence (BA/BE) studies in compliance with ethical standards and applicable regulatory requirements.
Click to read the full article.

To define the procedure for conducting mock runs prior to the initiation of Bioavailability/Bioequivalence (BA/BE) studies in order to simulate study activities, identify potential gaps, and ensure operational readiness of all departments involved.
Click to read the full article.

To establish a systematic process for planning, conducting, and documenting clinical site monitoring visits during Bioavailability/Bioequivalence (BA/BE) studies, ensuring adherence to protocols, Good Clinical Practice (GCP), and regulatory compliance.
Click to read the full article.

To define the standardized process for the identification, documentation, reporting, and resolution of protocol deviations occurring during the clinical phase of Bioavailability/Bioequivalence (BA/BE) studies, ensuring compliance with GCP and applicable regulations.
Click to read the full article.

To establish a standardized method for the monitoring, recording, and reviewing of ambient room temperature in sample collection areas during the conduct of Bioavailability/Bioequivalence (BA/BE) studies to maintain sample integrity and ensure protocol compliance.
Click to read the full article.

To define a standardized process for the use of Case Record Forms (CRFs) during the clinical phase of Bioavailability/Bioequivalence (BA/BE) studies, ensuring complete, accurate, and compliant documentation of clinical trial data.
Click to read the full article.